Hemodynamic effects of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone (Ro 7-2956): a nonadrenergic myocardial stimulant.
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D004285:Dogs; D004983:Ethanolamines / Q000494:pharmacology; D005112:Extracorporeal Circulation; D006321:Heart / Q000187:drug effects* / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects; D006614:Hindlimb / Q000098:blood supply; D006943:Hyperglycemia / Q000139:chemically induced; D007093:Imidazoles / Q000494:pharmacology*; D007545:Isoproterenol / Q000494:pharmacology; D007773:Lactates / Q000097:blood; D009119:Muscle Contraction / Q000187:drug effects; D010477:Perfusion; D013268:Stimulation, Chemical; D013610:Tachycardia / Q000139:chemically induced; D014665:Vasodilator Agents / Q000494:pharmacology
D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D007093:Imidazoles; D007773:Lactates; D014665:Vasodilator Agents; D007545:Isoproterenol